Skopos Bio
Next-generation radiopharmaceutical therapies for hard-to-treat cancers
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Skopos Bio is a Melbourne-based spinout from the Peter MacCallum Cancer Centre developing targeted radiopharmaceutical therapies for cancer, building on the theranostic approach of pairing imaging with treatment to reach oncology targets previously addressable only with conventional drugs. In late September 2026 the Australian Financial Review reported a $12 million seed round from Andrew Forrest's Tenmile, John Wylie's Tin Alley Ventures, and Reed Jobs' Yosemite to move its work toward human trials.
- Website
- skoposbio.com
- Location
- Melbourne, Australia
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageskoposbio.com
For agents
Nothing listed yet.